Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASC40 tablets in moderate to severe acne vulgaris (Phase II)
CTR20212992Phase 2Completed
- Sponsor
- Ascletis Pharma Inc.
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of denifanstat in acne vulgaris, sponsored by Ascletis Pharma Inc.. Started Dec 2021; status: completed.
02
Drugs
denifanstat
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on CTR20212992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20212992.